Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > why rvv will go to zero again
View:
Post by SmartPodhotzone on Jan 03, 2021 1:20pm

why rvv will go to zero again

St. Jude scientists identify possible COVID-19 treatment

Immunologists have determined the process driving life-threatening inflammation, lung damage and organ failure in patients with COVID-19
Comment by RiskyBiz928 on Jan 03, 2021 1:24pm
Your post in no way indicates why RVV will go to zero. IDIOT on the loose.
Comment by SmartPodhotzone on Jan 03, 2021 1:35pm
We have solved a major piece of the cytokine storm mystery by characterizing critical factors responsible for initiating this process, and thereby identifying a unique combination therapy using existing drugs that can be applied in the clinic to save lives,” Kanneganti said. The other authors are Shraddha Tuladhar, Parimal Samir, Min Zheng, Balamurugan Sundaram, Balaji Banoth, R. K. Subbarao ...more  
Comment by cool888 on Jan 03, 2021 1:40pm
Report this A** H*LE immediatley, this joker needs to be BANNED.
Comment by ginosailling on Jan 03, 2021 3:23pm
I when back a couple days and posted 18 complaint of abuse about him yesterday to stockhouse monitors , eventualy they will banne him , probably not many people working there this week but they shoyld be back tomorrow
Comment by Chrisxd5 on Jan 03, 2021 3:56pm
I already did 4 times dunno why his posts still allowed 
Comment by cool888 on Jan 03, 2021 4:09pm
Hopefully Tomorrow !
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities